Key Drivers
- Earnings Surge
- High Leverage
- Dividend Risk
AIAI Summary
ALX is a high-yield, asset-backed REIT—not a 7.9x earnings bargain—because its recent profit was largely driven by a one-time property sale; investors should demand proof that recurring rental cash flow can cover the ~7% dividend while leverage remains high, with the Target lease and stronger cash balance offering only partial support.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Earnings Surge
- •High Leverage
- •Dividend Risk
ALX's improved Q2 earnings, liquidity, and apparent valuation are tempered by high leverage, inconsistent cash flow, and an unsustainably high annual dividend payout.
Price Behavior
Key Price Behavior Insights:
- •Accelerating decline
- •Oversold momentum
- •Critical support
ALX fell 9.2% over the last month, remains weak below $260.90, and may bounce from $245–$247 support, but a break below $245 would reinforce the downtrend.
Accelerated selloff to $245.65 between 2026-09-08 and 2026-09-15
Sentiment & News
Key News Insights:
- •Peer comparisons
- •Investor conferences
- •No financial updates
Alexander's saw comparative stock analyses without a stated verdict, while ALX Oncology focused on September investor-conference outreach, signaling neutral near-term catalysts.
The coverage is unlikely to materially affect either instrument without new operating results, guidance, or transactions
Similar Companies in Real Estate
Other companies in the same sector with AI ratings